A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 3082048)

Published in Transplantation on March 01, 1986

Authors

D Guyotat, G Mauduit, B Chouvet, J Kanitakis, H V Van, D Fiere, J Thivolet

Articles by these authors

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis (2001) 12.73

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group. N Engl J Med (1997) 3.21

High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood (1993) 2.34

Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol (1983) 1.98

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia (2003) 1.96

Initial clonal acute lymphoblastic transformation of chronic lymphocytic leukemia with (11;14) and (8;12) chromosome translocations and acquired homozygosity. Acta Haematol (1988) 1.94

Experimental production of antibodies against stratum corneum keratin polypeptides. Arch Dermatol Res (1980) 1.87

Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood (1992) 1.80

Attempt to protect rabbits against experimental syphilis by passive immunization. Br J Vener Dis (1973) 1.68

Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant (2008) 1.65

Milia-like idiopathic calcinosis cutis. Pediatr Dermatol (2004) 1.57

Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis (1985) 1.54

External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53

Antinuclear autoantibodies in Swiss mice thymectomized at birth. Nature (1967) 1.50

Expression and activity of caspases 1 and 3 in myelodysplastic syndromes. Leukemia (2000) 1.48

PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant (2000) 1.44

Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia. Leukemia (1998) 1.44

Serum thymidine kinase in acute nonlymphoblastic leukemia. Leukemia (1988) 1.41

Diagnosing Pemphigus foliaceus: a retrospective analysis of clinical, histological and immunological criteria. Dermatology (2001) 1.40

Occurrence of T-cell lymphoma in a patient with acute myelogenous leukemia. Ann Hematol (1996) 1.39

[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39

The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant (2008) 1.39

Acute myelogenous leukaemia following exposure to microwaves. Br J Haematol (1989) 1.38

Skin cancer in organ transplant recipients--where do we stand today? Am J Transplant (2008) 1.35

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM). Blood (1997) 1.26

Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol (1996) 1.25

Cannabis arteritis. Br J Dermatol (2005) 1.24

Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang (1971) 1.23

Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet (1987) 1.22

Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol (1980) 1.18

Investigation of a specific IgM antibody test in neonatal congenital syphilis. Br J Vener Dis (1970) 1.14

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM). Br J Haematol (2000) 1.13

Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12

Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. Br J Dermatol (1977) 1.11

[Immunofluorescence studies of serum autoantibodies with respect to the constituents of the epidermis of burned patients]. Experientia (1968) 1.09

Interleukin-6 in normal skin and psoriasis. Acta Derm Venereol (1992) 1.09

Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression. Dermatologica (1987) 1.08

Congenital self-healing histiocytosis (Hashimoto-Pritzker). An ultrastructural and immunohistochemical study. Cancer (1988) 1.07

The atrophic variant of dermatofibrosarcoma protuberans in childhood: a report of six cases. Br J Dermatol (1998) 1.06

Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol (1983) 1.06

First human hand transplantation. Case report. Transpl Int (2000) 1.05

Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin. Br J Dermatol (1986) 1.05

Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia. Ann Hematol (2002) 1.04

[Scleroderma en coup de sabre with homolateral chronic glaucoma (author's transl)]. Ann Dermatol Venereol (1977) 1.00

Oral photochemotherapy in the treatment of lichen planus (LP). Clinical results, histological and ultrastructural observations. Br J Dermatol (1978) 1.00

Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem (1991) 1.00

[Australia antigen, virus hepatitis and periarteritis nodosa]. Presse Med (1970) 0.99

PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol (1979) 0.99

Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques. J Clin Oncol (2000) 0.99

Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98

Cutaneous leiomyomatosis with type 2 segmental involvement. J Dermatol (2001) 0.98

[Histomorphometric analysis of bone-marrow adipose density and heterogeneity in myeloid aplasia and dysplasia (author's transl)]. Pathol Biol (Paris) (1979) 0.98

Influence of cigarette smoking on the presentation and course of acute myeloid leukemia. Ann Oncol (2002) 0.98

Normal and psoriatic human skin grafts on "nude" mice: morphological and immunochemical studies. J Invest Dermatol (1981) 0.97

Morphological, immunological and immunocytochemical identification of lymphocytes extracted from cutaneous infiltrates. Clin Exp Immunol (1976) 0.97

[Maternally-transmitted severe neonatal aphthosis]. Ann Dermatol Venereol (1982) 0.97

Long-term follow-up in composite tissue allotransplantation: in-depth study of five (hand and face) recipients. Am J Transplant (2011) 0.97

CD4 antibody treatment of severe psoriasis. Lancet (1991) 0.96

Squamous cell carcinoma of the skin complicating lupus vulgaris. J Eur Acad Dermatol Venereol (2006) 0.96

Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing. Hum Mol Genet (1999) 0.96

Anti-D47: a monoclonal antibody reacting with the secretory cells of human eccrine sweat glands. Br J Dermatol (1983) 0.96

Lichen planus and chronic graft-versus-host reaction. In situ identification of immunocompetent cell phenotypes. J Cutan Pathol (1982) 0.96

Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD. J Invest Dermatol (2003) 0.96

In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations. Clin Exp Immunol (1982) 0.96

A case of disseminated Scedosporium apiospermum infection after bone marrow transplantation. Mykosen (1987) 0.95

Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoimmun (1992) 0.95

[Contribution to the study of the treponeme isolated from monkeys by A. Fribourg-Blanc]. Bull World Health Organ (1969) 0.94

Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. AIDS Res Hum Retroviruses (1989) 0.94

Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience. Am J Hematol (2001) 0.94

Bullous dermatosis and myeloma. Monoclonal anticytoplasmic antibody activity. Arch Dermatol (1980) 0.94

Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells. Br J Dermatol (1983) 0.93

Australia antigen and polyarteritis nodosa. Am J Dis Child (1972) 0.93

Keratin polypeptide modifications induced by human papilloma viruses (HPV). Arch Dermatol Res (1981) 0.93

[The electron of antibodies fixed in vivo the skin level in pemphigus, bullous pemphigoid and lupus erythematosus]. Lyon Med (1972) 0.93

Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis. Br J Dermatol (1984) 0.93

Generalized eruptive histiocytoma evolving into xanthoma disseminatum in a 4-year-old boy. Br J Dermatol (1995) 0.93

[Significance of anti-mitochondria antibodies in liver pathology and during syphilis]. Pathol Biol (Paris) (1973) 0.93

Comparative study of delayed hypersensitivity skin reactions and antibodies to human papilloma virus (HPV). Clin Exp Immunol (1977) 0.93

Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin. J Cutan Pathol (1989) 0.93

Bilateral hand transplantation: six years after the first case. Am J Transplant (2006) 0.92

Detection of human immunodeficiency virus-DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol (1991) 0.92

Sequence of changes in psoriatic epidermis. Immunocompetent cell redistribution precedes altered expression of keratinocyte differentiation markers. Acta Derm Venereol (1988) 0.92

[Leucocytoclastic vasculitis and sarcoidosis. Apropos of a case]. Ann Dermatol Venereol (1980) 0.92

Olmsted syndrome: report of two new cases and literature review. J Dermatol (2000) 0.92

Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes. Cell Death Dis (2012) 0.92

Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation (1986) 0.91

Cytokeratins in human basal and squamous cell carcinomas: biochemical, immunohistological findings and comparisons with normal epithelia. J Cutan Pathol (1982) 0.91